Posted in News
The Dictionary of Medicines and Devices (dm+d) has authored a VMP for tisagenlecelucel and the brand product Kymriah®. As this product is an autologous infusion of genetically modified cells, there is no precise ‘dose’ and the pack is described as 1 pack. As a result, all of the instances where this has been recorded in the pharmacy data from Trusts each description of bag, infusion or dose has been mapped to 1 pack.
It is possible to monitor the number of doses of tisagenlecelucel issued through pharmacy in this way, but taking into account the specialist nature of the product it is possible that not all doses are issued through pharmacy.